The FDA has approved a new nasal spray as a rapid treatment for migraine pain in adults. The spray may relieve pain and other migraine symptoms as soon as 15 minutes after use, drugmaker Pfizer says.
The nasal spray zavegepant, sold as Zavzpret, may relieve pain and other bothersome migraine symptoms as soon as 15 minutes after use, drugmaker Pfizer said in a news release. The drug is expected to be available in pharmacies in July 2023, the company said. There are already a number of different types of medications available to treat migraines, including several kinds of nasal sprays.
In one study published in the journal The Lancet Neurology, about 24% of people who took a single 10 milligram dose of Zavzpret reported they had no pain two hours later, compared with 15% of the group who got a nasal spray without any active ingredients, a difference that was statistically significant. The main side effect reported in the study was an altered sense of taste, which affected about 1 in 5 people who took the drug. Other side effects were nasal discomfort and nausea.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Pfizer wins FDA approval for its migraine nasal sprayPfizer Inc. said Friday the U.S. Food and Drug Administration has approved its migraine nasal spray Zavzpret. The treatment is the first and only calcitonin...
Consulte Mais informação »
FDA approves Pfizer's new nasal spray treatment for migrainesThe FDA approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant), the first and only migraine treatment offered in a nasal spray.
Consulte Mais informação »
US FDA approves Pfizer's pain-relief nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
Consulte Mais informação »
US FDA approves Pfizer's nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
Consulte Mais informação »
FDA proposes tobacco rules to make manufacturing more consistent and ingredients more transparent | CNNThe US Food and Drug Administration announced Wednesday that it is proposing new requirements for tobacco companies that would help prevent contamination of their products and set some standards for the way they make and package products so regulators and consumers will know precisely what is in them.
Consulte Mais informação »
FDA calls on baby formula industry to prevent bacterial illnesses | CNNThe US Food and Drug Administration's commissioner issued a letter calling to action the infant formula industry in order to protect babies from illnesses caused by salmonella and the bacteria Cronobacter sakazakii.
Consulte Mais informação »